| Literature DB >> 28056785 |
Li Ren1, Chenchen Tang1, Wuhui Li1, Jialin Cui1, Xingjun Tan1, Yafeng Xiong1, Jie Chen1, Jun Wang1, Jun Xiao1, Yi Zhou1, Jing Wang1, Min Tao1, Chun Zhang1, Shaojun Liu2.
Abstract
BACKGROUND: Polyploidy and hybridization are both recognized as major forces in evolution. Most of our current knowledge about differences in gene regulation in polyploid hybrids comes from plant studies. The gene expression of diverged genomes and regulatory interactions are still unclear in lower vertebrates.Entities:
Keywords: Biased expression; Dosage compensation; Genomic dominance; Transcriptome; Triploid
Mesh:
Year: 2017 PMID: 28056785 PMCID: PMC5216571 DOI: 10.1186/s12864-016-3424-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1The chromosomal trait and appearance of grass carp (maternal GC = 48), blunt snout bream (paternal BSB = 48) and their triploid offspring (GB = 72)
Summary of obtained transcriptome data
| BSB-1 | BSB-2 | BSB-3 | GC-1 | GC-2 | GC-3 | GB-1 | GB-2 | GB-3 | Total | Merge-sequences | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total reads (million) | 55.29 | 23.69 | 21.16 | 51.60 | 23.52 | 21.65 | 55.33 | 23.63 | 23.16 | 299.03 | |
| Total nucleotides (Gb) | 4.98 | 4.79 | 4.27 | 4.64 | 4.75 | 4.37 | 4.98 | 4.77 | 4.68 | 42.23 | |
| Total length (bp) | 40,397,155 | 36,773,931 | 40,344,526 | 117,515,612 | 77,813,385 | ||||||
| N50 length (bp) | 1,499 | 1,181 | 1,330 | 1,616 | |||||||
| Mean length (bp) | 788.70 | 710.65 | 734.73 | 813.08 | |||||||
| NO. assembled sequences (≥100 bp) | 51,220 | 51,747 | 54,911 | 157,878 | 95,702 | ||||||
| NO. assembled sequences (≥1000 bp) | 11,190 (21.85%) | 9,873 (19.08%) | 11,005 (20.04%) | 32,068 | |||||||
| Q20 percentage (%) | 97.1 | 93.88 | 93.78 | 97.9 | 93.57 | 92.49 | 97.04 | 92.35 | 93.16 | ||
| GC percentage (%) | 48.23 | 48.69 | 48.68 | 48.42 | 50.29 | 50.41 | 47.65 | 48.58 | 48.78 | ||
Fig. 2Differentially expressed genes in maternal GC, paternal BSB, and triploid offsprings GB. a. The different expression level between BSB and GC is shown. b. The different expression level between BSB and GB is shown. c. The different expression level between GC and GB is shown. The red (blue) points in the graph (MA-plot) are the genes that were identified as differentially expressed. The green points in the graph (MA-plot) are the genes that were not significantly different. Differentially expressed genes were identified using MA plot-based methods with a random sampling model and a p-value threshold of 0.001. d. Differentially expressed genes in each contrast between triploid offspring and their origin parents. Bold text exhibits the total number and fraction of genes differentially expressed in each contrast. Also shown for each contrast is the partitioning of the total number of differentially expressed genes into the direction of upregulation. For example, 4,822 genes are indicated as being differentially expressed between M. amblycephala and C. idellus. Of these, 2,376 are upregulated in C. idellus, and 2,446 genes are upregulated in M. amblycephala
Fig. 3Distribution of differentially expressed genes as compared AT-ELV with PT-ELV (a) and compared AT-ELV with PD-ELV (b) in MA plot. a. Compared AT-ELV and PT-ELV, Black dots between the two blue line represents the genes with no significant difference and others exhibit as significantly differential expression (>2-fold change and FDR < 0.05), respectively. b. Compared AT-ELV and PD-ELV, Black dots between the two blue line represents the genes with no significant difference and others exhibit as significantly differential expression (>2-fold change and FDR < 0.05), respectively. c. Bold text exhibits the total number and fraction of genes differentially expressed between the expressions of triploid offspring with the predicted expression of mid-parents in silico module of C2 + B and C + B
Fig. 4Partitioning of expression patterns in triploid. a. The 12 possible differential expression states in triploid. Roman numerals indicate the same categories that were used in Rappet et al. (2009) [32]. The respective gene expression patterns for the diploid parents and their triploid offspring are shown in the schematic graphs. b. GB expression levels (black spot in the dotted line) when paternal BSB (♂) has higher expression than maternal GC (♀). The significantly different expression levels in triploid that was lower than those in paternal BSB and higher than those in maternal GC show the mid-parents expression pattern (XI). If, however, the GB expression was not significantly different (threshold value of log2Ratio ≤ 1) from that of the parents (green spots), the ELD in the direction of paternal BSB or maternal GC can be explained by up- or downregulation of the BSB homoeolog (VII and IX). The significantly different expression levels in which triploid expression was higher than that of paternal BSB or maternal GC (red spot above the midpoint) or lower than that of paternal BSB or maternal GC (red spot below the midpoint) conformed to the upregulation (V) and downregulation (I) patterns, respectively. c. GB expression levels (black spot in the dotted line) if maternal GC (♀) has higher expression than paternal BSB (♂). d. GB expression levels (black spot in the dotted line) if the expression levels of paternal BSB or maternal GC were not significantly different
Basic information of differential expression growth genes among the triploid hybrids and its parents
| Categories | Ensembl protein id | BSB-RPKM | GB-RPKM | GC-RPKM | Symbols | Go term name | Go term accession |
|---|---|---|---|---|---|---|---|
| IX | ENSDARP00000003167 | 1.28 | 0.05 | 0.09 |
| positive regulation of vascular endothelial growth factor signaling pathway | GO:1900748 |
| XI | ENSDARP00000074846 | 10.44 | 4.68 | 2.00 |
| vascular endothelial growth factor receptor signaling pathway, regulation of organ growth | GO:0048010, GO:0046620 |
| XI | ENSDARP00000013686 | 4.94 | 1.97 | 0.59 |
| growth, growth factor activity | GO:0040007, GO:0008083 |
| III | ENSDARP00000072198 | 6.95 | 1.36 | 3.51 |
| transforming growth factor beta-activated receptor activity | GO:0005024 |
| IV | ENSDARP00000023951 | 2.24 | 8.00 | 3.67 |
| developmental growth | GO:0048589 |
| IX | ENSDARP00000102655 | 2.97 | 1.31 | 1.07 |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 |
| I | ENSDARP00000011459 | 2.40 | 0.16 | 0.42 |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 |
| IX | ENSDARP00000003654 | 9.23 | 0.88 | 0.57 |
| growth factor activity | GO:0008083 |
| XII | ENSDARP00000106837 | 0.15 | 1.88 | 5.17 |
| regulation of multicellular organism growth | GO:0040014 |
| XII | ENSDARP00000111890 | 0.62 | 2.54 | 7.51 |
| regulation of cell growth, insulin-like growth factor binding | GO:0001558, GO:0005520 |
| VIII | ENSDARP00000089039 | 2.43 | 1.83 | 7.18 |
| vascular endothelial growth factor receptor signaling pathway, vascular endothelial growth factor signaling pathway, regulation of vascular endothelial growth factor receptor signaling pathway, growth factor binding, vascular endothelial growth factor-activated receptor activity | GO:0048010, GO:0038084, GO:0030947, GO:0019838, GO:0005021 |
| VIII | ENSDARP00000091440 | 2.78 | 2.76 | 7.82 |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 |
| XII | ENSDARP00000110575 | 0.48 | 1.19 | 5.87 |
| vascular endothelial growth factor receptor signaling pathway, growth factor activity | GO:0048010 GO:0008083 |
| VII | ENSDARP00000050533 | 3.95 | 2.63 | 0.71 |
| regulation of cell growth, insulin-like growth factor binding | GO:0001558 GO:0005520 |
| XI | ENSDARP00000028652 | 17.97 | 7.00 | 2.72 |
| platelet-derived growth factor receptor signaling pathway, platelet-derived growth factor alpha-receptor activity | GO:0048008 GO:0005018 |
| XI | ENSDARP00000053094 | 3.57 | 1.61 | 0.63 |
| regulation of epidermal growth factor receptor signaling pathway, growth factor binding | GO:0042058 GO:0019838 |
| III | ENSDARP00000030150 | 4.56 | 1.24 | 6.39 |
| transforming growth factor beta receptor signaling pathway | GO:0007179 |
| XI | ENSDARP00000052422 | 5.17 | 1.31 | 0.49 |
| negative regulation of fibroblast growth factor receptor signaling pathway | GO:0040037 |
| VII | ENSDARP00000036006 | 3.67 | 2.64 | 0.89 |
| unidimensional cell growth | GO:0009826 |
| IX | ENSDARP00000071913 | 3.91 | 1.09 | 1.44 |
| transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor activity, type II | GO:0007179 GO:0005026 |
| III | ENSDARP00000031108 | 6.34 | 1.10 | 3.85 |
| transforming growth factor beta receptor signaling pathway | GO:0007179 |
| XII | ENSDARP00000002466 | 0.20 | 2.85 | 6.13 |
| vascular endothelial growth factor receptor signaling pathway, vascular endothelial growth factor-activated receptor activity | GO:0048010 GO:0005021 |
| IX | ENSDARP00000032226 | 8.98 | 3.64 | 3.80 |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 |
| X | ENSDARP00000007058 | 1.31 | 3.00 | 4.18 |
| unidimensional cell growth | GO:0009826 |
| IV | ENSDARP00000019643 | 23.24 | 54.31 | 25.38 |
| regulation of cell growth, insulin-like growth factor binding | GO:0001558 GO:0005520 |
| VIII | ENSDARP00000039831 | 2.31 | 2.47 | 6.37 |
| transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor activity, type II | GO:0007179 GO:0005026 |
| VI | ENSDARP00000057368 | 0.02 | 4.36 | 2.07 |
| regulation of cell growth, insulin-like growth factor binding | GO:0001558 GO:0005520 |
| IX | ENSDARP00000060763 | 8.41 | 2.71 | 2.02 |
| regulation of vascular endothelial growth factor receptor signaling pathway | GO:0030947 |
| VII | ENSDARP00000076657 | 5.77 | 5.22 | 1.11 |
| growth, growth factor activity | GO:0040007 GO:0008083 |
| IX | ENSDARP00000076455 | 5.53 | 1.00 | 1.56 |
| growth factor activity | GO:0008083 |
| XII | ENSDARP00000018513 | 0.32 | 1.72 | 7.99 |
| growth factor activity | GO:0008083 |
| IX | ENSDARP00000096601 | 10.28 | 3.34 | 2.55 |
| developmental growth | GO:0048589 |
| VII | ENSDARP00000047568 | 30.01 | 25.43 | 11.67 |
| forebrain development, fin regeneration, insulin-like growth factor receptor binding, growth factor activity | GO:0005159 GO:0008083 GO:0030900 GO:0031101 |
| IX | ENSDARP00000025519 | 5.09 | 1.37 | 1.12 |
| growth, transforming growth factor beta receptor signaling pathway, cell growth, growth factor activity, transforming growth factor beta receptor binding | GO:0040007 GO:0007179 GO:0016049 GO:0008083 GO:0005160 |
| II | ENSDARP00000056452 | 0.06 | 0.01 | 17.17 |
| regulation of cell growth, insulin-like growth factor binding, insulin-like growth factor I binding, insulin-like growth factor II binding | GO:0001558 GO:0005520 GO:0031994 GO:0031995 |
| VIII | ENSDARP00000058288 | 2.73 | 3.92 | 8.08 |
| transforming growth factor beta receptor signaling pathway | GO:0007179 |
| X | ENSDARP00000076869 | 1.53 | 3.92 | 4.53 |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 |
| VIII | ENSDARP00000103673 | 1.63 | 2.82 | 8.90 |
| growth factor activity | GO:0008083 |
| IV | ENSDARP00000017449 | 21.24 | 53.65 | 19.72 |
| growth factor activity, insulin-like growth factor receptor binding | GO:0008083 GO:0005159 |
| XI | ENSDARP00000032935 | 3.94 | 1.69 | 0.73 |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 |
| III | ENSDARP00000075360 | 5.09 | 2.16 | 6.13 |
| fibroblast growth factor receptor signaling pathway, fibroblast growth factor-activated receptor activity | GO:0008543 GO:0005007 |
| VIII | ENSDARP00000008469 | 1.43 | 1.84 | 7.07 |
| transforming growth factor beta-activated receptor activity | GO:0005024 |
| X | ENSDARP00000014981 | 1.46 | 3.34 | 6.61 |
| regulation of vascular endothelial growth factor signaling pathway | GO:1900746 |
| VII | ENSDARP00000069999 | 0.67 | 0.65 | 0.09 |
| growth, growth factor activity | GO:0040007 GO:0008083 |
| X | ENSDARP00000024277 | 5.83 | 18.91 | 19.20 |
| transforming growth factor beta receptor signaling pathway | GO:0007179 |
Fig. 5Real-time PCR analysis for ten differentially expressed genes: a. igf2b, Insulin-Like Growth Factor 2. b. igf1, Insulin-Like Growth Factor 1. c. gdf2. Growth Differentiation Factor 2. d. ctnnb1, Catenin (Cadherin-Associated Protein), Beta 1. e. gdf6a, Growth Differentiation Factor 6. f. igfbp2b, Insulin-Like Growth Factor Binding Protein 2 (g). igfbp5a, Insulin-Like Growth Factor Binding Protein 5. h. insra, Insulin Receptor. i. ppm1bb, Protein Phosphatase, Mg2+/Mn2+ Dependent, 1B. j. smad7, SMAD Family Member 7